SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is trending due to optimism surrounding upcoming data presentations at the World Muscle Society Congress, with the community anticipating positive results and potential label expansion for ELEVIDYS. Discussions also involve potential short squeezes and renewed investor confidence, with some speculating on a possible buyout. The community is focused on key presentations and data releases throughout the week.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending amid speculation about an undisclosed institutional investor who made a $75M private placement, boosting the company's AI connectivity solution prospects. The community is buzzing with possibilities, with NVIDIA being a popular guess due to POET's optical tech relevance for GPU clusters, and the reveal of the investor expected around Oct 17. Bullish sentiment is fueled by potential short and gamma squeezes as well as strong partnerships.

SPDR Gold Trust - SPDR Gold Shares ETF

SPDR Gold Shares ETF

SPDR Gold Shares ETF ($GLD) is trending as spot gold prices have crossed $4,000 for the first time in history, driving discussions about a potential blow-off top and the sustainability of the rally. Community members are debating technical indicators, safe-haven demand, and the impact of global economic uncertainty on gold's value, with some pointing to central bank buying and dollar strength as key factors. The conversation also includes perspectives on miners versus spot gold, and possible price targets.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is trending due to new multi-year AI cloud contracts, specifically related to NVIDIA Blackwell GPUs, with the community buzzing about the company's strategic pivot and potential for significant revenue growth. Bullish sentiment surrounds the contracts' average 2-year terms and 2-year payback, suggesting strong demand, while some analysts debate valuation amid the AI infrastructure race. The conversation also includes comparisons to peers and speculation about future partnerships.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull ($BULL) is trending as the lock-up period expiry looms, potentially increasing the float and causing price volatility, with some investors seeing this as a buying opportunity. The community is debating whether to buy shares or options, while others are concerned about potential dilution and comparing it to similar situations with $HOOD. Some traders express frustration with the stock's performance despite positive fundamentals and high short interest.

Galecto, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The firm is also involved in the development of small molecule inhibitors of galectin-3 and LOXL2. The company was founded by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye in 2011 and is headquartered in Boston, MA.

Galecto Inc

Galecto (GLTO) is trending due to significant price movement and high trading volume, sparking discussions about potential short squeezes and comparisons to similar volatile stocks like $SPRB. The community is actively debating entry and exit points, with some anticipating further upward momentum while others caution against a potential pump and dump. The stock's low float and high borrowing rates are also contributing factors to the ongoing speculation.

The 401jk (just kidding) meme is a satirical punch in the gut in the face of the concept of retirement and also the 401k. The 401k total holdings are valued at around $12 trillion USD and it is the most popular retirement savings plan in the US. As time passes forevermore true retirement, or as we like to call it real freedom will only become much harder and harder for people to attain.  Through meme fueled laser focus and cyperphunk ideology the 401jK meme retirement fund token and community aim to point out the absurdities of how rigged our current system is, and how only insiders and those with power are starting the benefit from the increased centralization of cryptocurrency.........while also aiming to flip the $12 trillion USD 401k system to achieve freedom before our backs and knees are breaking.

401jK

401jK is trending as the community rallies around its narrative of disrupting the traditional 401k retirement system. Community members express strong bullish sentiment and highlight the coin's potential for significant gains, despite some concerns about potential scams. The coin's limited supply and strong community engagement are also being touted as drivers for future growth.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape ($QS) is trending as investors speculate on potential OEM partnerships, particularly with Tesla and Toyota, following Murata's announcement about scaling high-volume separator production. Community discussions revolve around the company's solid-state battery technology and its potential to disrupt the EV battery market, with some highlighting government support and growing lithium production in the US as tailwinds. Bullish sentiment is fueled by anticipation of new deals and upcoming earnings, while bears cite potential delays in commercialization and the company's cash burn rate.

BTQ Technologies Corp. engages in the business of post-quantum encryption. It focuses on applications to the blockchain industry. Its products include PQScale, Keelug, Kenting, Preon, QPoW, and QByte. The company was founded by Nicolas Roussy Newton on March 26, 2021 and is headquartered in Vancouver, Canada.

BTQ Technologies Corp

BTQ Technologies is trending due to increased attention on quantum computing and cybersecurity, particularly after the company's co-founders joined full-time to accelerate quantum-safe technology. The community is discussing BTQ's potential in post-quantum cryptography, its partnerships, and its undervalued status compared to competitors in the quantum space. Some investors are drawing comparisons to other high-growth tech sectors and speculating on significant long-term gains.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

$TMC is trending as the deep-sea mining sector gains traction, with community members discussing potential short squeezes and a possible breakout. Optimism is fueled by anticipation of government partnerships and regulatory approvals, particularly the NOAA decision. Bullish investors are focused on the company's long-term potential in the critical minerals market.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

The Justice Department’s Antitrust Division said on Thursday that it requires broad divestitures to resolve the challenge to UnitedHealth Group Incorporated’s (UNH) planned $3.3 billion acquisition of home health and hospice services provider Amedisys Inc. (AMED).The proposed <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.justice.gov/opa/pr/justice-department-requires-broad-divestitures-resolve-challenge-unitedhealths-acquisition">settlement</a>, filed by the department and its state co-plaintiffs, would require UnitedHealth and Amedisys to divest 164 home health and hospice locations, including one affiliated palliative care facility, across 19 states, accounting for approximately $528 million in annual revenue. The locations are spread across Tennessee, Alabama, Georgia, South Carolina, Virginia, Pennsylvania, New York, West Virginia, and Mississippi, among others.The settlement would secure the largest divestiture of outpatient healthcare services to resolve a merger challenge by the number of facilities, the department said. On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/UNH">UNH</a> fell from ‘extremely bullish’ to ‘bullish’ territory over the past 24 hours, while message volume stayed at ‘high’ levels.<figure class="image"><img style="aspect-ratio:1366/132;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_07_at_12_31_56_PM_png_875db7d160.webp" alt="UNH's Sentiment Meter and Message Volume as of 12:30 p.m. ET on Aug. 7, 2025 | Source: Stocktwits" width="1366" height="132"><figcaption>UNH's Sentiment Meter and Message Volume as of 12:30 p.m. ET on Aug. 7, 2025 | Source: Stocktwits</figcaption></figure>Retail sentiment around <a href="https://stocktwits.com/symbol/AMED">Amedisys</a> trended in the ‘bullish’ territory, accompanied by ‘normal’ levels of retail chatter.<figure class="image"><img style="aspect-ratio:1358/126;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_07_at_12_33_41_PM_png_b432c28787.webp" alt="AMED's Sentiment Meter and Message Volume as of 12:33 p.m. ET on Aug. 7, 2025 | Source: Stocktwits" width="1358" height="126"><figcaption>AMED's Sentiment Meter and Message Volume as of 12:33 p.m. ET on Aug. 7, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user opined that the divestitures may reduce expected synergies.<stembedurl>https://stocktwits.com/Tokki_/message/624147426</stembedurl>Additionally, the department requires Amedisys to pay a $1.1 million civil penalty and train its corporate and field leadership on antitrust compliance for falsely certifying that the company had truthfully, correctly, and completely responded to the United States’ requests for documents.UNH’s Optum unit submitted a proposal to acquire Amedisys in June 2023. UNH had acquired Amedisys’s rival LHC Group earlier that year through a $5.4 billion deal. However, the U.S. Department of Justice and attorneys general from four U.S. states filed a lawsuit in November 2024 to block the acquisition.“Eliminating the competition between UnitedHealth and Amedisys would harm patients who receive home health and hospice services, insurers who contract for home health services, and nurses who provide home health and hospice services,” the department then said.While shares of UNH are down by 52% this year, AMED is up by 11%.&nbsp;Read also: <a href="https://stocktwits.com/news-articles/markets/equity/sarepta-gets-price-target-hike-from-wells-fargo/chrmBLTRd3a">This Pharma Stock Shot Up 8% Today, Gets A Price Target Hike From Wells Fargo: Here’s Why Retail Sees Opportunity</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a smartphone displays the logo of UnitedHealth Group Incorporated. (Photo illustration by Cheng Xin/Getty Images)

DOJ Requires Broad Divestitures, $1.1M Fine To Resolve UnitedHealth-Amedisys Merger Challenge: Retail Thinks It May Reduce Expected Synergies

The proposed settlement, filed by the department and its state co-plaintiffs, would require UnitedHealth and Amedisys to divest 164 home health and hospice locations, including one affiliated palliative care facility, across 19 states.

Equity

Amedisys (AMED) is a Top-Ranked Value Stock: Should You Buy?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Here's What Key Metrics Tell Us About Amedisys (AMED) Q2 Earnings

Although the revenue and EPS for Amedisys (AMED) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Amedisys (AMED) Beats Q2 Earnings and Revenue Estimates

Amedisys (AMED) delivered earnings and revenue surprises of +10.79% and +2.00%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Can BrightSpring's Q1 Strength Carry Through 2025 Headwinds?

Here's Why You Should Retain AMED Stock in Your Portfolio for Now

BrightSpring's Care Ratings Climb: Is Its Lead Sustainable?

Are Medical Stocks Lagging  Amedisys (AMED) This Year?

Can Revenue Cycle Operations Drive DVA Stock Before Q1 Earnings?

The DOJ Is Investigating UnitedHealth. Is UNH Stock a Buy, Sell, or Hold Now?

UnitedHealth stock tanked on reports of DOJ investigation. But analysts remain uber bullish on the healthcare services giant.

Amedisys, Inc. engages in the provision of healthcare services. It operates through the following business segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment delivers services in the homes of individuals who may be recovering from an illness, injury, or surgery. The Hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness. The Personal Care segment gives patients assistance with the essential activities of daily living. The High Acuity Care segment includes providing home care recovery for high acuity patients on either a full risk or limited risk basis. The company was founded in 1982 and is headquartered in Baton Rouge, LA.

Amedisys Inc.

Will JP Morgan Chase ($JPM) beat quarterly earnings?  
 
*Powered by Polymarket

Stocktwits

JPMorgan Chase & Co

) beat quarterly earnings?  
 
*Powered by Polymarket

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	$1.14	--	--	N/A
Q2 '25	$1.36	$1.54	13.57%	BEAT
Q1 '25	$1.11	$1.25	12.96%	BEAT
Q4 '24	$1.05	$0.96	-8.35%	MISSED
Q3 '24	$1.15	$1.00	-12.75%	MISSED

AMED Amedisys Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q3 '25

Historical Earnings

Latest AMED News